Features and benefits of this thoroughly-researched and highly-regarded management report:
 High quality: Original research, novel 5-year market forecasts and informed commentary from our experienced editors are allied with unrivalled primary source data
 Global coverage: Covers leading economies as well as key emerging markets such as Russia and Brazil
 Issue driven: Understand the latest company, product, and regulatory developments
 Company Focus: Who’s working with whom? Who’s suing whom? Who’s up, who’s down? Detailed and frank appraisals of 27 leading companies in the field
 Flexible formats: Available in pdf or print with Espicom Interactive access included in the price. Cost-effective distribution licences can ensure you get the best from your investment
 http://bharatbook.com/market-research-reports/healthcare-market-research-report/the-world-generic-market-report-2012.html
 
 Easily understand the threats and opportunities that are shaping this rapidly evolving sector!
 Industry consolidation, new market opportunities, the latest on biosimilars plus much, much more! This leading report, now in its 10th year of publication, draws on primary research with companies, statistics offices, health ministries and trade associations worldwide and provides standard, comparative data and discussion on key issues. This extensive data set is interpreted and evaluated by the editors to provide a complete and compelling review of the whole sector. Industry Report
 
 Key facts, issues and questions
 * What branded companies are taking an interest in generics – we identify and assess the latest developments
 * What has Teva been up to in Japan in 2011?
 * Biosimilars get ever closer – latest regulatory data update
 * Which Mediterranean country might expect a generic sector average growth rate of 14.8% a year to 2016?
 * The political, regulatory and funding background in key markets
 * What pricing and production issue must generic companies overcome in Brazil?
 * Low market penetration of generics makes Italy an attractive proposition for generic manufacturers but what are the challenges?
 * How generic companies are faring in the recession
 * Who is involved in the latest legal challenges and litigation?
 
 VOLUME I: COMPANY PROFILES
 Industry Issues
 Industry consolidation
 The impact of the economic downturn
 Regulation & confusion in the USA
 European generic opportunities
 Progress with biosimilars
 Prospects for growth in key markets
 
 Extensive company profiles covering
 Financial performance
 ANDAs and launched products
 M&A activity and litigation
 
 For more information kindly visit :
 The World Generic Market Report 2012
 
 Or
 
 Bharat Book Bureau
 Tel: +91 22 27810772 / 27810773
 Fax: + 91 22 27812290
 Email: info@bharatbook.com
 Website: www.bharatbook.com
 Follow us on twitter: http://twitter.com/#!/Sandhya3B